We are live on ! Find out more
IMNN icon

Imunon
IMNN

34 hedge funds and large institutions have $8.44M invested in Imunon in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 36 → 34 (-2)

18% less capital invested

Capital invested by funds: $10.3M → $8.44M (-$1.87M)

32% less call options, than puts

Call options by funds: $2.66M | Put options by funds: $3.9M

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

73% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 11

Holders
34
Holders Change
-2
Holders Change %
-5.56%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
11
Closed
6
Calls
$2.66M
Puts
$3.9M
Net Calls
-$1.24M
Net Calls Change
+$1.83M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$157K
2
Renaissance Technologies
Renaissance Technologies
New York
+$157K
3
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$105K
4
BRWM
B. Riley Wealth Management
Tennessee
+$17.4K
5
U
UBS
Switzerland
+$17.4K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$131K
2
Millennium Management
Millennium Management
New York
-$113K
3
ARTA
A.R.T. Advisors
New York
-$95.8K
4
CS
Credit Suisse
Switzerland
-$90K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$87.1K

IMNN Hedge Fund Activity: Q3 2014 in Review

34 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2014, worth a combined $8.44M — down 18% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IMNN and 4 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 3 added.

The largest buyer was Goldman Sachs, adding an estimated $157K. The largest seller was Sabby Management, cutting an estimated $131K.

  • 34 institutional investors held Imunon (IMNN) as of Q3 2014, down from 36 in Q2 2014.
  • Funds reported $8.44M of Imunon stock for Q3 2014, down 18% quarter-over-quarter.
  • 4 funds opened new Imunon positions in Q3 2014 and 6 closed out, a net change of -2 holders.
  • The largest Imunon buyer in Q3 2014 was Goldman Sachs, an estimated $157K added.
  • The largest Imunon seller in Q3 2014 was Sabby Management, an estimated $131K sold.

Based on aggregated 13F filings for Q3 2014.